Cite

HARVARD Citation

    Wehrli, M. et al. (2022). Single-center experience using anakinra for steroid-refractory immune effector cell-associated neurotoxicity syndrome (ICANS). Journal for immunotherapy of cancer. 10 (1), p. . [Online]. 
  
Back to record